133 results on '"Chen, Bernadette"'
Search Results
2. Primary pulmonary vein stenosis among premature infants with single-vessel disease
3. Primary pulmonary vein stenosis among premature infants with single-vessel disease
4. Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn.
5. Plasma Asymmetric Dimethylarginine Levels Are Increased in Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
6. Hypoxic pulmonary endothelial cells release epidermal growth factor leading to vascular smooth muscle cell arginase‐2 expression and proliferation
7. Mitogen-activated protein kinase phosphatase-1 controls PD-L1 expression by regulating type I interferon during systemic Escherichia coli infection
8. Cyclooxygenase-2 deficiency attenuates lipopolysaccharide-induced inflammation, apoptosis, and acute lung injury in adult mice
9. Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn
10. Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness
11. Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia
12. Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation
13. Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells
14. Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase
15. Treatment Of Human Pulmonary Microvascular Endothelial Cells with NO leads to Increased PDE3A Protein Expression and AMPK Activation
16. Pharmacologic Agents Elevating cAMP Prevent Arginase II Expression and Proliferation of Pulmonary Artery Smooth Muscle Cells
17. Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cells
18. Primary pulmonary vein stenosis among premature infants with single-vessel disease
19. Nitric oxide activates AMPK by modulating PDE3A in human pulmonary artery smooth muscle cells
20. The Role of Phosphodiesterase (Pde) 3B in the Inflammatory Response of Macrophages to LPS
21. Therapies that enhance pulmonary vascular NO-signaling in the neonate
22. ErbB Family Members in Human Pulmonary Microvascular Endothelial Cells Respond Differently when Exposed to Hypoxia
23. Cell Type‐Specific Differential Effects of Nitric Oxide on PDE3 Expression in Pulmonary Vasculature
24. Deficiency of the Arginase 2 Gene Protects Neonatal Mice from Hyperoxia‐Induced Lung Injury
25. Isoform‐specific Pde3 knockout mice spontaneously develop pulmonary hypertension
26. Toll‐like receptor 4 antagonist protects neonatal mice from hyperoxia‐induced alveolar simplification
27. Hypoxic-induction of arginase II requires EGF-mediated EGFR activation in human pulmonary microvascular endothelial cells
28. Hypoxia Upregulates ErbB Family Members in Human Pulmonary Microvascular Endothelial Cells
29. Arginase II Regulates NO‐mediated Human Pulmonary Microvascular Endothelial Cell Migration
30. Hypoxic proliferation requires EGFR-mediated ERK activation in human pulmonary microvascular endothelial cells
31. Hypoxia induces arginase II expression and increases viable human pulmonary artery smooth muscle cell numbers via AMPKα1 signaling
32. Arginase 2 knockout mice are protected against hypoxia‐induced pulmonary hypertension
33. COL4A1 Mutation in a Neonate With Intrauterine Stroke and Anterior Segment Dysgenesis
34. An arginase-1 SNP that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia enhances NO-mediated apoptosis in lymphocytes
35. The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells
36. The Src Family Tyrosine Kinase fyn Protects Mice from Inflammation‐induced Lung Injury
37. Hypoxia Stimulates ERK via EGFR Activation in Human Pulmonary Microvascular Endothelial Cells
38. Hypoxia‐induced Arginase II Expression Depends on EGF‐mediated Activation of EGFR
39. Glutathione Reductase Facilitates Host Defense by Sustaining Phagocytic Oxidative Burst and Promoting the Development of Neutrophil Extracellular Traps1
40. Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells
41. The Src Family Tyrosine Kinases yes and src Have Divergent Effects on Cytokine‐Induced Apoptosis in Pulmonary Endothelial Cells Through Divergent Downstream Effects on PI3K and ERK Pathways
42. Hypoxia Activates Extracellular Signal‐Regulated Kinase (ERK) via EGFR Activation in Human Pulmonary Microvascular Endothelial Cells
43. Mice Deficient in the Src Family Tyrosine Kinase yes are Protected from Hyperoxia‐Induced Lung Injury
44. Stimulated Lymphocytes from Patients with ARG1 Single Nucleotide Polymorphism rs2781666 have Augmented NO Production in Hyperoxia
45. Hypoxic‐Induction of Arginase II is Associated with EGFR Activation and EGF Production
46. Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling
47. Arginase II is a target of miR-17-5p and regulates miR-17-5p expression in human pulmonary artery smooth muscle cells
48. The Src family tyrosine kinase, fyn, is a negative regulator of inflammation‐induced apoptosis in the lung (1176.6)
49. Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation
50. Pde3a‐deficient mice have evidence of pulmonary hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.